miR-205-5p expression in melanoma cell lines not only controlled the expression of TNFAIP8 but also increased sensitivity towards vemurafenib, a skin cancer drug currently used for the treatment of patients affected by advanced melanoma with B-RAFV600E mutant kinase57. The gene discussed is TNFAIP8; the disease is skin neoplasm.